| Akcje zaległe | 36,695,155 shares |
| Akcje insidera | 47 566 307 shares |
| Insiderzy ogółem | 43 |
Wynik sentymentu insiderów
Ocena sentymentu insiderów pokazuje firmy, które są kupowane przez insiderów korporacyjnych.
Jest to wynik zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje spółki o najwyższym poziomie akumulacji informacji poufnych. Model rankingowy wykorzystuje kombinację liczby netto insiderów kupujących w ciągu ostatnich 90 dni, całkowitej liczby akcji kupionych jako procent akcji w obrocie oraz całkowitej liczby akcji posiadanych przez insiderów. Liczba ta waha się od 0 do 100, przy czym wyższe liczby wskazują na wyższy poziom akumulacji w porównaniu z innymi spółkami, a 50 to średnia.
Częstotliwość aktualizacji: codziennie
Ocena sentymentu kadry kierowniczej
Ocena sentymentu kadry kierowniczej pokazuje, że firmy są kupowane przez urzędników korporacyjnych.
Z definicji dyrektorzy korporacyjni to insiderzy korporacyjni, ale w przeciwieństwie do niektórych innych insiderów (10% akcjonariuszy i członków zarządu), dyrektorzy pracują dla firmy na co dzień i podczas handlu korzystają z własnych pieniędzy. (10% Akcjonariusze i członkowie zarządu często zarządzają funduszami zarządzających pieniędzmi innych osób). W związku z tym transakcje wykorzystujące informacje poufne dokonywane przez osoby z kadry kierowniczej mają znacznie większe znaczenie i powinny być odpowiednio traktowane.
Podobnie jak ocena sentymentu insiderów, ocena sentymentu kadry kierowniczej jest wynikiem zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje firmy o najwyższym poziomie akumulacji urzędników.
Częstotliwość aktualizacji: codziennie
Kluczowe wskaźniki insider
Ta karta pokazuje pozycję firmy według różnych wskaźników insider. Ranking według miary percentyla pokazuje, jak ta firma wypada na tle innych firm na rynkach amerykańskich. Wyższe rankingi wskazują na lepszą sytuację.
Na przykład ogólnie przyjmuje się, że kupowanie przez insiderów jest pozytywnym wskaźnikiem, zatem spółki z większą liczbą takich transakcji plasowałyby się wyżej niż spółki z mniejszą liczbą takich transakcji (lub nawet sprzedaży przez insiderów.
Liczba netto zakupów dokonanych przez insiderów (ranking)
6076 out of 10948
Liczba netto zakupów dokonanych przez insiderów to łączna liczba insiderów kupujących pomniejszona o całkowitą liczbę insiderów sprzedających w ciągu ostatnich 90 dni. Tutaj pokazana jest miara percentyla (zakres od 0 do 100%).
Procent akcji kupowanych przez insiderów (ranking)
5990 out of 10786
Procent akcji zakupionych przez insiderów to całkowita liczba akcji zakupionych przez insiderów pomniejszona o całkowitą liczbę akcji sprzedanych przez insiderów w ciągu ostatnich 90 dni, podzielona przez całkowitą liczbę akcji zakupionych przez insiderów i pomnożona przez 100.
Wykres handlu insider
Poniższy wykres przedstawia Armata Pharmaceuticals, Inc. transakcji zrealizowanych przez insiderów. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Ogólnie rzecz biorąc, dokonywanie transakcji w ich firmach przez osoby posiadające dostęp do informacji poufnych w oparciu o istotne, niepubliczne informacje jest generalnie nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4.
Lista insiderów i wskaźniki rentowności
Ta tabela przedstawia listę znanych insiderów i jest generowana automatycznie na podstawie zgłoszeń ujawnianych SEC. Oprócz nazwisk, najnowszego tytułu oraz oznaczenia dyrektora, członka kierownictwa lub 10% właściciela, podajemy najnowsze ujawnione pakiety akcji. Dodatkowo, jeśli to możliwe, udostępniamy historyczne wyniki handlowe danego insidera. Historyczne wyniki handlowe to średnia ważona wyników rzeczywistych transakcji zakupu na otwartym rynku dokonanych przez insiderów. Więcej informacji na temat sposobu obliczania tej wartości obejrzyj webinar na YouTube.
See our leaderboard of most profitable insider traders.
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|---|---|---|
| Richard Bastiani Director - [D] | 27 778 | 27 778 | |
| Igor Bilinsky Chief Operating Officer - [O] | 0 | 0 | |
|
Biogen Idec Ma Inc
10% Owner -
|
11 926 948 | 11 926 948 | |
|
Biogen Inc.
10% Owner -
|
11 926 948 | 11 926 948 | |
| Jack L Bowman Director - [D] | 10 500 | 10 500 | |
| Richard Bear | 27 383 | ||
| Deborah Birx Chief Executive Officer, Director - [D] [O] | 212 458 | 212 458 | |
| Barrie J Phd Carter Executive Vice President - [O] | 48 766 | 48 766 | |
| Jeremy Curnock Cook Director - [D] | 411 105 | 411 105 | |
| Joseph Md Phd Davie Director - [D] | 11 000 | 11 000 | |
| Louis Drapeau Director - [D] | 10 000 | 10 000 | |
|
Delta Dental Plan of Michigan, Inc.
10% Owner -
|
2 531 604 | 2 531 604 | |
|
Delta Dental of Wisconsin, Inc.
10% Owner -
|
2 586 356 | 2 586 356 | |
|
Corp Plc Elan
10% Owner -
|
11 626 282 | 11 626 282 |
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|---|---|---|
|
Elan International Services Ltd
10% Owner -
|
11 626 282 | 11 626 282 | |
| Paul C Grint Chief Executive Officer, Director - [D] [O] | 599 | 599 | |
| Roger Hawley Director - [D] | 10 000 | 10 000 | |
| Jules Haimovitz | 33 000 | ||
|
Corp Intrexon
10% Owner -
|
674 169 | 674 169 | |
|
Innoviva Strategic Opportunities LLC
Director, 10% Owner -
[D]
|
16 365 969 | 16 365 969 | |
|
Innoviva, Inc.
Director, 10% Owner -
[D]
|
16 365 969 | 16 365 969 | |
| Johnson Wendy S. Interim Chief Operating Office, Director - [D] [O] | 1 000 | 1 000 | |
|
Randal J Kirk
10% Owner -
|
674 169 | 674 169 | |
| Kirk Julian P. | 16 200 | ||
| Odysseas D Kostas | 33 000 | ||
| Robin Kramer | 33 000 | ||
| Pierre Kyme Chief Business Officer - [O] | 9 461 | 9 461 | |
| Nelson L Levy Director - [D] | 10 070 | 10 070 |
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|---|---|---|
| Steven Robert Martin Chief Financial Officer - [O] | 3 760 | 3 760 | |
| Duane Alfred Morris VP of Operations - [O] | 52 288 | 52 288 | |
| H Stewart Parker Director - [D] | 27 778 | 27 778 | |
| Joseph M Patti | 33 000 | ||
| Michael S Perry Director - [D] | 411 105 | 411 105 | |
| Todd Patrick Chief Executive Officer, Director - [D] [O] | 408 172 | 408 172 | |
| Peterson Todd C. | 33 000 | ||
| David J Poston CFO & VP Finance - [O] | 36 700 | 36 700 | |
|
Holding Co Renaissance
10% Owner -
|
2 531 604 | 2 531 604 | |
| BG Susan Robinson President and CEO - [O] | 66 915 | 66 915 | |
| Richard Rychlik Corporate Controller and PFO - [O] | 10 000 | 10 000 | |
| Vijay B Samant | 10 900 | ||
| Michael Scott Salka Chief Executive Officer, Director - [D] [O] | 11 200 | 11 200 | |
| Schlesinger Sarah J. | 33 000 | ||
| Brian Varnum President and CDO - [O] | 64 324 | 64 324 |
Report errors via our new Insider Auditing Tool
Śledź historię zakupów insiderów — analiza zysków krótkoterminowych
W tej sekcji analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w ARMP / Armata Pharmaceuticals, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Śledź historię sprzedaży insider — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży insidera na otwartym rynku dokonanej w ARMP / Armata Pharmaceuticals, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia transakcji
Kliknij ikonę linku, aby zobaczyć pełną historię transakcji. Transakcje zgłoszone w ramach automatycznego planu handlowego 10b5-1 będą oznaczone znakiem X w kolumnie oznaczonej 10b-5.
| Plik Data |
Data transakcji |
Formularz | Wtajemniczony | Serce | Nazwa papieru wartościowego | Kod | Bezpośredni | Cena wykonania |
Cena jednostki |
Zmieniono jednostki |
Zmieniona wartość (1 tys.) |
Pozostałe opcje |
Pozostałe akcje |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | 2026-03-14 | 4 | Kyme Pierre | ARMP | Common Stock | D | 10,5400 | -1 030 | -11 | 9 461 | ||||
| 2026-03-17 | 2026-03-14 | 4 | Birx Deborah | ARMP | Common Stock | D | 10,5400 | -4 919 | -52 | 212 458 | ||||
| 2025-07-14 | 2025-07-10 | 4 | Birx Deborah | ARMP | Common Stock | D | 2,2700 | -13 637 | -31 | 217 377 | ||||
| 2025-04-25 | 2025-03-14 | 4 | Kyme Pierre | ARMP | Common Stock | D | 1,9500 | -1 027 | -2 | 10 491 | ||||
| 2025-04-25 | 2025-03-14 | 4 | Birx Deborah | ARMP | Common Stock | D | 1,9500 | -6 061 | -12 | 231 014 | ||||
| 2025-04-25 | 2024-07-10 | 4 | Birx Deborah | ARMP | Common Stock | D | 2,6800 | -22 925 | -61 | 237 075 | ||||
| 2025-04-25 | 3/A | Kyme Pierre | ARMP | Common Stock | D | 1 518 | ||||||||
| 2024-06-28 | 3 | Kyme Pierre | ARMP | Common Stock | D | 10 000 | ||||||||
| 2024-03-18 | 2024-03-14 | 4 | Rychlik Richard | ARMP | Common Stock | D | 10 000 | 10 000 | ||||||
| 2024-03-18 | 2024-03-14 | 4 | Birx Deborah | ARMP | Common Stock | D | 60 000 | 260 000 | ||||||
| 2023-12-26 | 2023-12-21 | 4 | Birx Deborah | ARMP | Common Stock | D | 200 000 | 200 000 | ||||||
| 2022-04-15 | 2022-04-13 | 4 | Peterson Todd C. | ARMP | Stock Options (Right to Buy) | D | 5,11 | 33 000 | 33 000 | |||||
| 2022-04-15 | 2022-04-13 | 4 | Schlesinger Sarah J. | ARMP | Stock Options (Right to Buy) | D | 5,11 | 33 000 | 33 000 | |||||
| 2022-04-15 | 2022-04-13 | 4 | Patrick Todd | ARMP | Stock Options (Right to Buy) | D | 5,11 | 33 000 | 33 000 | |||||
| 2022-04-15 | 2022-04-13 | 4 | Kramer Robin | ARMP | Stock Options (Right to Buy) | D | 5,11 | 33 000 | 33 000 | |||||
| 2022-04-15 | 2022-04-13 | 4 | Kostas Odysseas D | ARMP | Stock Options (Right to Buy) | D | 5,11 | 33 000 | 33 000 | |||||
| 2022-04-15 | 2022-04-13 | 4 | PATTI JOSEPH M | ARMP | Stock Options (Right to Buy) | D | 5,11 | 33 000 | 33 000 | |||||
| 2022-04-15 | 2022-04-13 | 4 | Morris Duane Alfred | ARMP | Stock Options (Right to Buy) | D | 5,11 | 41 000 | 41 000 | |||||
| 2022-04-15 | 2022-04-13 | 4 | Haimovitz Jules | ARMP | Stock Options (Right to Buy) | D | 5,11 | 33 000 | 33 000 | |||||
| 2022-04-15 | 2022-04-13 | 4 | Varnum Brian | ARMP | Stock Options (Right to Buy) | D | 5,11 | 240 000 | 240 000 | |||||
| 2022-04-01 | 2022-03-31 | 4 | Innoviva, Inc. See footnotes | ARMP | Warrants to Purchase Common Stock | I | 5,00 | 5,0000 | 0 | 0 | 2 692 604 | |||
| 2022-04-01 | 2022-03-31 | 4 | Innoviva, Inc. See footnotes | ARMP | Common Stock | I | 5,0000 | 5 385 208 | 26 926 | 16 365 969 | ||||
| 2022-02-11 | 2022-02-09 | 4 | Innoviva, Inc. See footnotes | ARMP | Warrants to Purchase Common Stock | I | 5,00 | 5,0000 | 1 807 396 | 9 037 | 1 807 396 | |||
| 2022-02-11 | 2022-02-09 | 4 | Innoviva, Inc. See footnotes | ARMP | Common Stock | I | 5,0000 | 3 614 792 | 18 074 | 10 980 761 | ||||
| 2021-11-01 | 2021-10-29 | 4 | Innoviva, Inc. See footnotes | ARMP | Common Stock | I | 3,3000 | 1 212 122 | 4 000 | 7 365 969 | ||||
| 2021-08-03 | 2021-08-02 | 4 | Varnum Brian | ARMP | Stock Option (Right to Buy) | D | 3,82 | 125 000 | 125 000 | |||||
| 2021-06-09 | 2021-06-07 | 4 | Schlesinger Sarah J. | ARMP | Stock Option (Right to Buy) | D | 4,29 | 28 000 | 28 000 | |||||
| 2021-06-09 | 2021-06-07 | 4 | Kostas Odysseas D | ARMP | Stock Option (Right to Buy) | D | 4,29 | 28 000 | 28 000 | |||||
| 2021-06-09 | 2021-06-07 | 4 | Kramer Robin | ARMP | Stock Option (Right to Buy) | D | 4,29 | 28 000 | 28 000 | |||||
| 2021-06-09 | 2021-06-07 | 4 | PATTI JOSEPH M | ARMP | Stock Option (Right to Buy) | D | 4,29 | 28 000 | 28 000 | |||||
| 2021-06-09 | 2021-06-07 | 4 | Peterson Todd C. | ARMP | Stock Option (Right to Buy) | D | 4,29 | 28 000 | 28 000 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Haimovitz Jules | ARMP | Stock Option (Right to Buy) | D | 4,74 | 30 000 | 30 000 | |||||
| 2021-03-26 | 2021-03-25 | 4 | Varnum Brian | ARMP | Stock Option (Right to Buy) | D | 5,14 | 112 000 | 112 000 | |||||
| 2021-03-26 | 2021-03-25 | 4 | Morris Duane Alfred | ARMP | Stock Option (Right to Buy) | D | 5,14 | 28 000 | 28 000 | |||||
| 2021-03-26 | 2021-03-25 | 4 | Patrick Todd | ARMP | Stock Option (Right to Buy) | D | 5,14 | 112 000 | 112 000 | |||||
| 2021-03-26 | 2021-03-25 | 4 | Martin Steven Robert | ARMP | Stock Option (Right to Buy) | D | 5,14 | 56 000 | 56 000 | |||||
| 2021-03-17 | 2021-03-17 | 4 | Innoviva, Inc. See Footnotes | ARMP | Warrants to Purchase Common Stock | I | 3,25 | 3,2500 | 4 285 935 | 13 929 | 6 153 847 | |||
| 2021-03-17 | 2021-03-17 | 4 | Innoviva, Inc. See Footnotes | ARMP | Common Stock | I | 3,2500 | 4 285 935 | 13 929 | 6 153 847 | ||||
| 2021-01-28 | 2021-01-26 | 4 | Innoviva, Inc. See Footnotes | ARMP | Warrants to Purchase Common Stock | I | 3,25 | 3,2500 | 1 867 912 | 6 071 | 1 867 912 | |||
| 2021-01-28 | 2021-01-26 | 4 | Innoviva, Inc. See Footnotes | ARMP | Common Stock | I | 3,2500 | 1 867 912 | 6 071 | 1 867 912 | ||||
| 2020-12-09 | 2020-12-08 | 4 | Morris Duane Alfred | ARMP | Stock Option (Right to Buy) | D | 3,15 | 23 000 | 23 000 | |||||
| 2020-12-09 | 2020-12-08 | 4 | Peterson Todd C. | ARMP | Stock Option (Right to Buy) | D | 3,15 | 23 000 | 23 000 | |||||
| 2020-12-09 | 2020-12-08 | 4 | PATTI JOSEPH M | ARMP | Stock Option (Right to Buy) | D | 3,15 | 23 000 | 23 000 | |||||
| 2020-12-09 | 2020-12-08 | 4 | Patrick Todd | ARMP | Stock Option (Right to Buy) | D | 3,15 | 23 000 | 23 000 | |||||
| 2020-12-09 | 2020-12-08 | 4 | Kostas Odysseas D | ARMP | Stock Option (Right to Buy) | D | 3,15 | 23 000 | 23 000 | |||||
| 2020-12-09 | 2020-12-08 | 4 | BASTIANI RICHARD | ARMP | Stock Option (Right to Buy) | D | 3,15 | 23 000 | 23 000 | |||||
| 2020-12-09 | 2020-12-08 | 4 | Varnum Brian | ARMP | Stock Option (Right to Buy) | D | 3,15 | 23 000 | 23 000 | |||||
| 2020-12-09 | 2020-12-08 | 4 | Schlesinger Sarah J. | ARMP | Stock Option (Right to Buy) | D | 3,15 | 23 000 | 23 000 | |||||
| 2020-12-09 | 2020-12-08 | 4 | Martin Steven Robert | ARMP | Stock Option (Right to Buy) | D | 3,15 | 23 000 | 23 000 | |||||
| 2020-12-09 | 2020-12-08 | 4 | Kramer Robin | ARMP | Stock Option (Right to Buy) | D | 3,15 | 30 000 | 30 000 | |||||
| 2020-03-31 | 2020-03-27 | 4 | Innoviva, Inc. | ARMP | Warrants to Acquire Common Stock | D | 2,87 | 2,8700 | 7 717 661 | 22 150 | 8 710 800 | |||
| 2020-03-31 | 2020-03-27 | 4 | Innoviva, Inc. | ARMP | Common Stock | D | 2,8700 | 7 717 661 | 22 150 | 8 710 800 | ||||
| 2020-02-14 | 2019-05-09 | 5 | PERRY MICHAEL S | ARMP | Warrant to Purchase Common Stock | I | 0,32 | 12 065,4600 | -46 666 | -563 047 | 0 | |||
| 2020-02-14 | 2019-05-09 | 5 | COOK JEREMY CURNOCK | ARMP | Warrant to Purchase Common Stock | I | 0,32 | 12 065,4600 | -46 666 | -563 047 | 0 | |||
| 2020-02-14 | 2020-02-12 | 4 | Kostas Odysseas D | ARMP | Stock Option (Right to Buy) | D | 4,17 | 27 383 | 27 383 | |||||
| 2020-02-14 | 2020-02-12 | 4 | Schlesinger Sarah J. | ARMP | Stock Option (Right to Buy) | D | 4,17 | 27 383 | 27 383 | |||||
| 2020-02-14 | 3 | Innoviva, Inc. | ARMP | Common Stock | D | 1 986 278 | ||||||||
| 2020-02-14 | 3 | Innoviva, Inc. | ARMP | Common Stock | D | 1 986 278 | ||||||||
| 2020-02-14 | 3 | Innoviva, Inc. | ARMP | Common Stock | D | 1 986 278 | ||||||||
| 2019-10-15 | 2019-10-10 | 4 | Peterson Todd C. | ARMP | Stock Option (Right to Buy) | D | 3,77 | 27 383 | 27 383 | |||||
| 2019-05-24 | 2019-05-22 | 4 | BASTIANI RICHARD | ARMP | Stock Option (Right to Buy) | D | 3,15 | 27 383 | 27 383 | |||||
| 2019-05-24 | 2019-05-22 | 4 | COOK JEREMY CURNOCK | ARMP | Stock Option (Right to Buy) | D | 3,15 | 27 383 | 27 383 | |||||
| 2019-05-24 | 2019-05-22 | 4 | PARKER H STEWART | ARMP | Stock Option (Right to Buy) | D | 3,15 | 27 383 | 27 383 | |||||
| 2019-05-24 | 2019-05-22 | 4 | PERRY MICHAEL S | ARMP | Stock Option (Right to Buy) | D | 3,15 | 27 383 | 27 383 | |||||
| 2019-05-24 | 2019-05-22 | 4 | PATTI JOSEPH M | ARMP | Stock Option (Right to Buy) | D | 3,15 | 27 383 | 27 383 | |||||
| 2019-05-24 | 2019-05-22 | 4 | Martin Steven Robert | ARMP | Stock Option (Right to Buy) | D | 3,15 | 149 362 | 149 362 | |||||
| 2019-05-24 | 2019-05-22 | 4 | Bear Richard | ARMP | Stock Option (Right to Buy) | D | 3,15 | 27 383 | 27 383 | |||||
| 2019-05-24 | 2019-05-22 | 4 | Patrick Todd | ARMP | Stock Option (Right to Buy) | D | 3,15 | 298 724 | 298 724 | |||||
| 2019-05-24 | 2019-05-22 | 4 | Morris Duane Alfred | ARMP | Stock Option (Right to Buy) | D | 3,15 | 74 681 | 74 681 | |||||
| 2019-05-24 | 2019-05-22 | 4 | Varnum Brian | ARMP | Stock Option (Right to Buy) | D | 3,15 | 298 724 | 298 724 | |||||
| 2019-05-20 | 3 | Delta Dental of Wisconsin, Inc. | ARMP | Common Stock | D | 3 736 669 | ||||||||
| 2019-05-20 | 3 | Delta Dental of Wisconsin, Inc. | ARMP | Common Stock | I | 2 586 356 | ||||||||
| 2019-05-20 | 3 | Delta Dental of Wisconsin, Inc. | ARMP | Common Stock | D | 3 736 669 | ||||||||
| 2019-05-20 | 3 | Delta Dental of Wisconsin, Inc. | ARMP | Common Stock | I | 2 586 356 | ||||||||
| 2019-05-20 | 3 | Delta Dental of Wisconsin, Inc. | ARMP | Common Stock | I | 2 586 356 | ||||||||
| 2019-05-20 | 3 | Delta Dental of Wisconsin, Inc. | ARMP | Common Stock | D | 3 736 669 | ||||||||
| 2019-05-17 | 3 | Renaissance Holding Co | ARMP | Common Stock | I | 2 531 604 | ||||||||
| 2019-05-17 | 3 | Renaissance Holding Co | ARMP | Common Stock | I | 2 531 604 | ||||||||
| 2019-05-17 | 3 | Renaissance Holding Co | ARMP | Common Stock | I | 2 531 604 | ||||||||
| 2019-05-17 | 3 | Renaissance Holding Co | ARMP | Common Stock | I | 2 531 604 | ||||||||
| 2019-05-16 | 3 | Varnum Brian | ARMP | Common Stock | D | 64 324 | ||||||||
| 2019-05-16 | 3 | Varnum Brian | ARMP | Common Stock | D | 64 324 | ||||||||
| 2019-05-16 | 3 | Varnum Brian | ARMP | Common Stock | D | 64 324 | ||||||||
| 2019-05-16 | 3 | Morris Duane Alfred | ARMP | Common Stock | D | 52 288 | ||||||||
| 2019-05-16 | 3 | Morris Duane Alfred | ARMP | Common Stock | D | 52 288 | ||||||||
| 2019-05-16 | 3 | Morris Duane Alfred | ARMP | Common Stock | D | 52 288 | ||||||||
| 2019-05-16 | 3 | Patrick Todd | ARMP | Common Stock | D | 408 172 | ||||||||
| 2019-05-16 | 3 | Patrick Todd | ARMP | Common Stock | D | 408 172 | ||||||||
| 2019-05-16 | 3 | Patrick Todd | ARMP | Common Stock | D | 408 172 | ||||||||
| 2019-05-16 | 3 | PARKER H STEWART | ARMP | Common Stock | D | 27 778 | ||||||||
| 2019-05-16 | 3 | PARKER H STEWART | ARMP | Common Stock | D | 27 778 | ||||||||
| 2019-05-16 | 3 | PARKER H STEWART | ARMP | Common Stock | D | 27 778 | ||||||||
| 2019-05-16 | 3 | BASTIANI RICHARD | ARMP | Common Stock | D | 27 778 | ||||||||
| 2019-05-16 | 3 | BASTIANI RICHARD | ARMP | Common Stock | D | 27 778 | ||||||||
| 2019-05-16 | 3 | BASTIANI RICHARD | ARMP | Common Stock | D | 27 778 | ||||||||
| 2018-03-26 | 2018-03-22 | 4 | COOK JEREMY CURNOCK | APHB | Common Stock | I | 1,1000 | 181 820 | 200 | 411 105 | ||||
| 2018-03-26 | 2017-09-19 | 4 | COOK JEREMY CURNOCK | APHB | Common Stock | I | 105 015 | 229 285 | ||||||
| 2018-03-26 | 2017-06-29 | 4 | COOK JEREMY CURNOCK | APHB | Common Stock | I | 5 757 | 124 270 | ||||||
| 2018-03-26 | 2016-11-22 | 4 | COOK JEREMY CURNOCK | APHB | Warrant to Purchase Common Stock | I | 0,57 | 0,1000 | 46 666 | 5 | 46 666 | |||
| 2018-03-26 | 2016-11-22 | 4 | COOK JEREMY CURNOCK | APHB | Common Stock | I | 7,4000 | 46 666 | 345 | 118 513 | ||||
| 2018-03-26 | 2016-06-21 | 4 | COOK JEREMY CURNOCK | APHB | Common Stock | I | 15 057 | 71 847 | ||||||
| 2018-03-26 | 2018-03-22 | 4 | PERRY MICHAEL S | APHB | Common Stock | I | 1,1000 | 181 820 | 200 | 411 105 | ||||
| 2018-03-26 | 2017-09-19 | 4 | PERRY MICHAEL S | APHB | Common Stock | I | 105 015 | 229 285 | ||||||
| 2018-03-26 | 2017-06-29 | 4 | PERRY MICHAEL S | APHB | Common Stock | I | 5 757 | 124 270 | ||||||
| 2017-12-12 | 2017-12-08 | 4 | GRINT PAUL C | APHB | Common Stock | D | 0,6200 | 599 | 0 | 599 | ||||
| 2017-09-12 | 2017-09-07 | 4 | PERRY MICHAEL S | APHB | Stock Option (Right to Buy) | D | 0,91 | 10 900 | 10 900 | |||||
| 2017-09-12 | 2017-09-07 | 4 | SAMANT VIJAY B | APHB | Stock Option (Right to Buy) | D | 0,91 | 10 900 | 10 900 | |||||
| 2017-09-11 | 2017-09-07 | 4 | DRAPEAU LOUIS | APHB | Stock Option (Right to Buy) | D | 0,91 | 10 900 | 10 900 | |||||
| 2017-09-11 | 2017-09-07 | 4 | Johnson Wendy S. | APHB | Stock Option (Right to Buy) | D | 0,91 | 10 900 | 10 900 | |||||
| 2017-09-11 | 2017-09-07 | 4 | GRINT PAUL C | APHB | Stock Option (Right to Buy) | D | 0,91 | 285 113 | 285 113 | |||||
| 2017-09-11 | 2017-09-07 | 4 | GRINT PAUL C | APHB | Stock Option (Right to Buy) | D | 0,91 | 190 076 | 190 076 | |||||
| 2017-09-11 | 2017-09-07 | 4 | Martin Steven Robert | APHB | Stock Option (Right to Buy) | D | 0,91 | 139 000 | 139 000 | |||||
| 2017-09-11 | 2017-09-07 | 4 | COOK JEREMY CURNOCK | APHB | Stock Option (Right to Buy) | D | 0,91 | 10 900 | 10 900 | |||||
| 2017-06-01 | 2017-05-30 | 4 | BILINSKY IGOR | APHB | Stock Option (Right to Buy) | D | 0,74 | 87 161 | 87 161 | |||||
| 2017-04-04 | 2017-04-01 | 4 | Salka Michael Scott | APHB | Stock Option (Right to Buy) | D | 0,43 | 214 214 | 214 214 | |||||
| 2017-04-04 | 2017-04-01 | 4 | Martin Steven Robert | APHB | Stock Option (Right to Buy) | D | 0,43 | 161 290 | 161 290 | |||||
| 2017-04-04 | 2017-04-01 | 4 | BILINSKY IGOR | APHB | Stock Option (Right to Buy) | D | 0,43 | 176 411 | 176 411 | |||||
| 2017-01-31 | 3 | BILINSKY IGOR | APHB | Common Stock | D | 0 | ||||||||
| 2017-01-31 | 2017-01-30 | 4 | BILINSKY IGOR | APHB | Stock Option (Right to Buy) | D | 0,46 | 247 322 | 247 322 | |||||
| 2016-12-29 | 2016-12-29 | 4 | KIRK RANDAL J by Intrexon | APHB | Common Stock | I | 0,4500 | -20 077 | -9 | 674 169 | ||||
| 2016-12-29 | 2016-12-29 | 4 | KIRK RANDAL J by NRM VII Holdings | APHB | Common Stock | I | 0,4500 | -21 923 | -10 | 736 170 | ||||
| 2016-12-29 | 2016-12-28 | 4 | KIRK RANDAL J by Intrexon | APHB | Common Stock | I | 0,4700 | -40 450 | -19 | 694 246 | ||||
| 2016-12-29 | 2016-12-28 | 4 | KIRK RANDAL J by NRM VII Holdings | APHB | Common Stock | I | 0,4700 | -44 170 | -21 | 758 093 | ||||
| 2016-12-29 | 2016-12-27 | 4 | KIRK RANDAL J by Intrexon | APHB | Common Stock | I | 0,5100 | -24 092 | -12 | 734 696 | ||||
| 2016-12-29 | 2016-12-27 | 4 | KIRK RANDAL J by NRM VII Holdings | APHB | Common Stock | I | 0,5100 | -26 308 | -13 | 802 263 | ||||
| 2016-12-13 | 2016-12-09 | 4 | Salka Michael Scott | APHB | Common Stock | D | 0,3900 | 7 000 | 3 | 11 200 | ||||
| 2016-12-13 | 2016-12-09 | 4 | Martin Steven Robert | APHB | Common Stock | D | 0,3900 | 3 760 | 1 | 3 760 | ||||
| 2016-11-16 | 2016-11-12 | 4 | KIRK RANDAL J by NRM VII Holdings | APHB | Series B Preferred Stock | I | -2 142 857 | 0 | ||||||
| 2016-11-16 | 2016-11-12 | 4 | KIRK RANDAL J by NRM VII Holdings | APHB | Common Stock | I | 428 571 | 828 571 | ||||||
| 2016-04-12 | 3/A | COOK JEREMY CURNOCK | APHB | Common Stock | I | 120 000 | ||||||||
| 2016-04-12 | 2016-04-08 | 4 | COOK JEREMY CURNOCK | APHB | Warrant to Purchase Common Stock | I | 4,05 | 35 714 | 35 714 | |||||
| 2016-04-12 | 2016-04-08 | 4 | COOK JEREMY CURNOCK | APHB | Warrant to Purchase Common Stock | I | 7,00 | -35 714 | 0 | |||||
| 2016-04-12 | 2016-04-08 | 4 | COOK JEREMY CURNOCK | APHB | Series B Convertible Preferred Stock | I | -1 040 753 | 0 | ||||||
| 2016-04-12 | 2016-04-08 | 4 | COOK JEREMY CURNOCK | APHB | Warrant to Purchase Common Stock | I | 4,05 | 0,0010 | 34 184 | 0 | 34 184 | |||
| 2016-04-12 | 2016-04-08 | 4 | COOK JEREMY CURNOCK | APHB | Series B Convertible Preferred Stock | I | 0,8100 | 326 468 | 264 | 1 040 753 | ||||
| 2016-04-12 | 2016-04-08 | 4 | COOK JEREMY CURNOCK | APHB | Common Stock | I | 171 298 | 567 903 | ||||||
| 2016-04-12 | 2016-04-08 | 4 | COOK JEREMY CURNOCK | APHB | Common Stock | I | 208 150 | 396 605 | ||||||
| 2016-04-12 | 2015-03-16 | 4 | COOK JEREMY CURNOCK | APHB | Warrant to Purchase Common Stock | I | 10,75 | 10,7500 | 17 114 | 184 | 17 114 | |||
| 2016-04-12 | 2015-03-16 | 4 | COOK JEREMY CURNOCK | APHB | Common Stock | I | 8,2500 | 68 455 | 565 | 188 455 | ||||
| 2016-01-20 | 3 | Martin Steven Robert | APHB | Common Stock | D | 0 | ||||||||
| 2016-01-20 | 2016-01-18 | 4 | Martin Steven Robert | APHB | Stock Option (Right to Buy) | D | 2,85 | 99 919 | 99 919 | |||||
| 2015-11-09 | 2015-11-05 | 4 | GRINT PAUL C | APHB | Stock Option (Right to Buy) | D | 5,65 | 16 200 | 16 200 | |||||
| 2015-11-09 | 2015-11-05 | 4 | SAMANT VIJAY B | APHB | Stock Option (Right to Buy) | D | 5,65 | 16 200 | 16 200 | |||||
| 2015-10-07 | 2015-10-05 | 4 | Johnson Wendy S. | APHB | Common Stock | D | 4,4270 | 1 000 | 4 | 1 000 | ||||
| 2015-10-07 | 2015-10-06 | 4 | DRAPEAU LOUIS | APHB | Common Stock | D | 4,3900 | 10 000 | 44 | 10 000 | ||||
| 2015-10-06 | 2015-10-05 | 4 | Salka Michael Scott | APHB | Common Stock | D | 4,7500 | 4 200 | 20 | 4 200 | ||||
| 2015-09-23 | 2015-09-21 | 4 | Johnson Wendy S. | APHB | Stock Option (right to buy) | D | 6,38 | 16 200 | 16 200 | |||||
| 2015-09-23 | 2015-09-21 | 4 | PERRY MICHAEL S | APHB | Stock Option (right to buy) | D | 6,38 | 12 800 | 12 800 | |||||
| 2015-09-23 | 2015-09-21 | 4 | DRAPEAU LOUIS | APHB | Stock Option (right to buy) | D | 6,38 | 13 800 | 13 800 | |||||
| 2015-09-23 | 2015-09-21 | 4 | COOK JEREMY CURNOCK | APHB | Stock Option (right to buy) | D | 6,38 | 38 500 | 38 500 | |||||
| 2015-09-23 | 2015-09-21 | 4 | Kirk Julian P. | APHB | Option to Purchase Common Stock | D | 6,38 | 16 200 | 16 200 | |||||
| 2015-09-10 | 2015-09-08 | 4 | Johnson Wendy S. | APHB | Stock Option (right to buy) | D | 7,46 | 49 965 | 49 965 | |||||
| 2015-08-06 | 2015-08-05 | 4 | Salka Michael Scott | APHB | Stock Option (right to buy) | D | 0,19 | 19 985 810 | 19 985 810 | |||||
| 2015-03-18 | 2015-03-16 | 4 | KIRK RANDAL J by Intrexon Corporation | APHB | Warrant to Purchase Common Stock | I | 0,22 | 3 484 848 | 3 484 848 | |||||
| 2015-03-18 | 2015-03-16 | 4 | KIRK RANDAL J by Intrexon Corporation | APHB | Common Stock | I | 0,1650 | 13 939 392 | 2 300 | 37 939 392 | ||||
| 2014-02-18 | 3 | INTREXON CORP by Intrexon Corporation | APHB | Common Stock | I | 68 000 000 | ||||||||
| 2014-02-18 | 3 | INTREXON CORP by Intrexon Corporation | APHB | Common Stock | I | 68 000 000 | ||||||||
| 2014-02-18 | 3 | INTREXON CORP by Intrexon Corporation | APHB | Common Stock | I | 68 000 000 | ||||||||
| 2014-02-18 | 3 | INTREXON CORP by NRM VII Holdings | APHB | Common Stock | I | 64 000 000 | ||||||||
| 2014-02-18 | 3 | INTREXON CORP by NRM VII Holdings | APHB | Common Stock | I | 64 000 000 | ||||||||
| 2014-02-18 | 3 | INTREXON CORP by NRM VII Holdings | APHB | Common Stock | I | 64 000 000 | ||||||||
| 2014-02-18 | 3 | PERRY MICHAEL S | APHB | Common Stock | D | 90 000 | ||||||||
| 2014-02-18 | 3 | PERRY MICHAEL S | APHB | Common Stock | D | 90 000 | ||||||||
| 2014-02-18 | 3 | COOK JEREMY CURNOCK | APHB | Common Stock | D | 130 000 | ||||||||
| 2014-02-18 | 3 | COOK JEREMY CURNOCK | APHB | Common Stock | D | 130 000 | ||||||||
| 2008-11-17 | 3 | Robinson BG Susan | TGEN | Common Stock | D | 66 915 | ||||||||
| 2007-05-21 | 2007-05-17 | 4 | BOWMAN JACK L | TGEN | Common Stock | D | 10 000 | 10 500 | ||||||
| 2007-05-21 | 2007-05-17 | 4 | CARTER BARRIE J PHD | TGEN | Common Stock | D | 35 000 | 48 766 | ||||||
| 2007-05-21 | 2007-05-17 | 4 | COOK JEREMY CURNOCK | TGEN | Common Stock | D | 15 000 | 15 000 | ||||||
| 2007-05-21 | 2007-05-17 | 4 | DAVIE JOSEPH MD PHD | TGEN | Common Stock | D | 10 000 | 11 000 | ||||||
| 2007-05-21 | 2007-05-17 | 4 | HAWLEY ROGER | TGEN | Common Stock | D | 10 000 | 10 000 | ||||||
| 2007-05-21 | 2007-05-17 | 4 | LEVY NELSON L | TGEN | Common Stock | D | 10 000 | 10 070 | ||||||
| 2007-05-21 | 2007-05-17 | 4 | PARKER H STEWART | TGEN | Common Stock | D | 50 000 | 81 175 | ||||||
| 2007-05-21 | 2007-05-17 | 4 | PERRY MICHAEL S | TGEN | Common Stock | D | 10 000 | 10 000 | ||||||
| 2007-05-21 | 2007-05-17 | 4 | Poston David J | TGEN | Common Stock | D | 35 000 | 36 700 | ||||||
| 2005-11-02 | 3 | PERRY MICHAEL S | TGEN | Common Stock | D | 0 | ||||||||
| 2005-10-04 | 3 | Poston David J | TGEN | Common Stock | D | 17 000 | ||||||||
| 2005-08-16 | 3 | HAWLEY ROGER | TGEN | Np securities held | D | 0 | ||||||||
| 2005-07-27 | 2005-07-26 | 4 | BIOGEN INC. By Biogen Idec MA, Inc. | TGEN | Common Stock, $0.01 Par Value | I | 0,8700 | -2 500 | -2 | 11 926 948 | ||||
| 2005-07-27 | 2005-07-26 | 4 | BIOGEN INC. By Biogen Idec MA, Inc. | TGEN | Common Stock, $0.01 Par Value | I | 0,8600 | -25 660 | -22 | 11 929 448 | ||||
| 2005-07-27 | 2005-07-26 | 4 | BIOGEN INC. By Biogen Idec MA, Inc. | TGEN | Common Stock, $0.01 Par Value | I | 0,8500 | -11 200 | -10 | 11 955 108 | ||||
| 2005-07-27 | 2005-07-26 | 4 | BIOGEN INC. By Biogen Idec MA, Inc. | TGEN | Common Stock, $0.01 Par Value | I | 0,8300 | -10 640 | -9 | 11 966 308 | ||||
| 2005-07-27 | 2005-07-26 | 4 | BIOGEN INC. By Biogen Idec MA, Inc. | TGEN | Common Stock, $0.01 Par Value | I | 0,8200 | -12 500 | -10 | 11 976 948 | ||||
| 2005-07-27 | 2005-07-26 | 4 | BIOGEN INC. By Biogen Idec MA, Inc. | TGEN | Common Stock, $0.01 Par Value | I | 0,8100 | -2 500 | -2 | 11 989 448 | ||||
| 2005-07-27 | 2005-07-25 | 4 | BIOGEN INC. by Biogen Idec MA, Inc. | TGEN | Common Stock, $0.01 Par Value | I | 0,7900 | -8 500 | -7 | 11 991 948 | ||||
| 2005-07-12 | 3 | BIOGEN IDEC MA INC By Biogen Idec MA, Inc. | TGEN | Common Stock, $0.01 Par Value | I | 851 873 | ||||||||
| 2005-07-12 | 3 | BIOGEN IDEC MA INC By Biogen Idec MA, Inc. | TGEN | Common Stock, $0.01 Par Value | I | 508 673 | ||||||||
| 2005-07-12 | 3 | BIOGEN IDEC MA INC By Biogen Idec MA, Inc. | TGEN | Common Stock, $0.01 Par Value | I | 3 060 754 | ||||||||
| 2005-07-12 | 2003-08-15 | 4 | BIOGEN INC. By Biogen Idec MA, Inc. | TGEN | Common Stock, $0.01 Par Value | I | 1,9100 | 2 515 843 | 4 805 | 12 127 178 | ||||
| 2005-07-12 | 2002-11-06 | 4 | BIOGEN INC. By Biogen Idec MA, Inc. | TGEN | Common Stock, $0.01 Par Value | I | 1,0700 | -210 819 | -226 | 9 611 335 | ||||
| 2005-07-12 | 2002-09-30 | 4 | BIOGEN INC. By Biogen Idec MA, Inc. | TGEN | Common Stock, $0.01 Par Value | I | 0,5500 | 104 854 | 58 | 9 400 516 | ||||
| 2005-01-10 | 2005-01-06 | 4 | ELAN CORP PLC I | TGEN | Common Stock | I | 1,7500 | -43 600 | -76 | 11 626 282 | ||||
| 2005-01-06 | 2005-01-05 | 4 | ELAN CORP PLC I | TGEN | Common Stock | I | 1,7500 | -225 335 | -394 | 11 669 882 | ||||
| 2005-01-06 | 2005-01-05 | 4 | ELAN CORP PLC I | TGEN | Common Stock | I | 1,7600 | -14 465 | -25 | 11 895 217 | ||||
| 2005-01-06 | 2005-01-05 | 4 | ELAN CORP PLC I | TGEN | Common Stock | I | 1,8000 | -10 200 | -18 | 11 909 682 | ||||
| 2005-01-06 | 2005-01-04 | 4 | ELAN CORP PLC I | TGEN | Common Stock | I | 1,7000 | -77 919 | -132 | 11 919 882 | ||||
| 2005-01-06 | 2005-01-04 | 4 | ELAN CORP PLC I | TGEN | Common Stock | I | 1,7100 | -1 750 | -3 | 11 997 801 | ||||
| 2005-01-06 | 2005-01-04 | 4 | ELAN CORP PLC I | TGEN | Common Stock | I | 1,7200 | -7 591 | -13 | 11 999 551 | ||||
| 2005-01-06 | 2005-01-04 | 4 | ELAN CORP PLC I | TGEN | Common Stock | I | 1,7500 | -24 500 | -43 | 12 007 142 | ||||
| 2005-01-06 | 2005-01-04 | 4 | ELAN CORP PLC I | TGEN | Common Stock | I | 1,7600 | -3 800 | -7 | 12 031 642 | ||||
| 2005-01-06 | 2005-01-04 | 4 | ELAN CORP PLC I | TGEN | Common Stock | I | 1,7700 | -20 690 | -37 | 12 035 442 | ||||
| 2005-01-06 | 2005-01-04 | 4 | ELAN CORP PLC I | TGEN | Common Stock | I | 1,7800 | -6 400 | -11 | 12 056 132 | ||||
| 2005-01-06 | 2005-01-04 | 4 | ELAN CORP PLC I | TGEN | Common Stock | I | 1,8000 | -1 400 | -3 | 12 062 532 | ||||
| 2005-01-06 | 2005-01-04 | 4 | ELAN CORP PLC I | TGEN | Common Stock | I | 1,8100 | -950 | -2 | 12 063 932 | ||||
| 2004-04-02 | 2004-03-31 | 4 | ELAN CORP PLC I | TGEN | Series B Convertible Exchangeable Preferred Stock | I | 3,32 | -12 015 | 0 | |||||
| 2004-04-02 | 2004-03-31 | 4 | ELAN CORP PLC I | TGEN | Common Stock | I | 3,3200 | 4 330 000 | 14 376 | 12 064 882 | ||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Series B Convertible Exchangeable Preferred Stock | I | 3,32 | 0 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 2,09 | 302 934,0000 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 2,80 | 63 420,0000 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 1,88 | 190 800,0000 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 0,57 | 127 200,0000 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 0,49 | 134 832,0000 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 0,65 | 57 000,0000 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 0,83 | 180 000,0000 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 0,96 | 120 000,0000 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 1,19 | 127 200,0000 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 1,95 | 950 000,0000 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 2,48 | 3 000 000,0000 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 3,78 | 2 000 000,0000 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 3,70 | 120 000,0000 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 6,11 | 2 000 000,0000 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 2,09 | 302 934,0000 | ||||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Common Stock | I | 0,4900 | 277 775 | 136 | 7 734 882 | ||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Common Stock | I | 0,5700 | 221 757 | 126 | 7 457 106 | ||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Common Stock | I | 0,6500 | 87 922 | 57 | 7 235 349 | ||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Common Stock | I | 0,8300 | 217 549 | 181 | 7 147 427 | ||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Common Stock | I | 0,9600 | 124 630 | 120 | 6 929 878 | ||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Common Stock | I | 1,1900 | 107 044 | 127 | 6 805 248 | ||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Common Stock | I | 1,8800 | 101 439 | 191 | 6 698 204 | ||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Common Stock | I | 1,9500 | 487 248 | 950 | 6 596 765 | ||||
| 2003-11-05 | 2003-09-02 | 4 | ELAN CORP PLC N/A | TGEN | Common Stock | I | 2,0900 | 3 577 879 | 7 478 | 6 109 517 | ||||
| 2003-11-05 | 2003-08-09 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 2,80 | 63 420,0000 | ||||||
| 2003-11-05 | 2003-06-28 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 1,88 | 190 800,0000 | ||||||
| 2003-11-05 | 2003-04-25 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 0,57 | 127 200,0000 | ||||||
| 2003-11-05 | 2003-03-26 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 0,49 | 134 832,0000 | ||||||
| 2003-11-05 | 2003-02-09 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 0,65 | 57 000,0000 | ||||||
| 2003-11-05 | 2002-12-28 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 0,83 | 180 000,0000 | ||||||
| 2003-11-05 | 2002-10-25 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 0,96 | 120 000,0000 | ||||||
| 2003-11-05 | 2002-09-26 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 1,19 | 127 200,0000 | ||||||
| 2003-11-05 | 2002-08-09 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 1,95 | 950 000,0000 | ||||||
| 2003-11-05 | 2002-06-28 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 2,48 | 3 000 000,0000 | ||||||
| 2003-11-05 | 2002-04-25 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 3,78 | 2 000 000,0000 | ||||||
| 2003-11-05 | 2002-03-26 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 3,70 | 120 000,0000 | ||||||
| 2003-11-05 | 2001-09-26 | 4 | ELAN CORP PLC N/A | TGEN | Convertible Promissory Note | I | 6,11 | 2 000 000,0000 | ||||||
| 2003-11-05 | 2000-08-09 | 4 | ELAN CORP PLC N/A | TGEN | Common Stock | I | 13,0640 | 382 739 | 5 000 | 2 531 638 |
P
Otwarty rynek lub prywatny zakup niepochodnych lub pochodnych papierów wartościowych
S
Otwarty rynek lub prywatna sprzedaż niepochodnych lub pochodnych papierów wartościowych
A
Grant, nagroda lub inne nabycie papierów wartościowych od spółki (np. opcja)
C
Konwersja instrumentu pochodnego
D
Sprzedaż lub przeniesienie papierów wartościowych z powrotem do spółki
F
Zapłata ceny wykonania lub zobowiązania podatkowego z wykorzystaniem części papierów wartościowych otrzymanych od spółki
G
Darowizna papierów wartościowych przez lub na rzecz insidera
K
Swapy kapitałowe i podobne transakcje zabezpieczające
M
Wykonanie lub konwersja pochodnego papieru wartościowego otrzymanego od spółki (takiego jak opcja)
V
Transakcja dobrowolnie zgłoszona na Formularzu 4
J
Inne (wraz z przypisem opisującym transakcję)
